Durable Survival Outcomes in Primary and Secondary Central Nervous System Lymphoma After High-dose Chemotherapy and Autologous Stem Cell Transplantation Using a Thiotepa, Busulfan, and Cyclophosphamide Conditioning Regimen

BACKGROUND: High-dose chemotherapy (HDC) with autologous stem cell transplantation (ASCT) has been investigated in patients with primary central nervous system lymphoma (PCNSL) and non-Hodgkin lymphoma (NHL) with CNS involvement and has shown promising results. PATIENTS AND METHODS: A retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Young, Patricia A., Gaut, Daria, Kimaiyo, Davis K., Grotts, Jonathan, Romero, Tahmineh, Chute, John, Schiller, Gary, de Vos, Sven, Eradat, Herbert A., Timmerman, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138188/
https://www.ncbi.nlm.nih.gov/pubmed/32229199
http://dx.doi.org/10.1016/j.clml.2020.02.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138188/
https://www.ncbi.nlm.nih.gov/pubmed/32229199
http://dx.doi.org/10.1016/j.clml.2020.02.009

Ejemplares similares